Aβ1-42 promotes microglial activation and apoptosis in the progression of AD by binding to TLR4
Authors:
Preprint
- 25 September 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Alzheimer's disease (AD) is one of the most common age-related neurodegenerative diseases and the most devastating form of senile dementia. It has a complex mechanism and no effective treatment. Exploring the pathogenesis of AD and providing ideas for treatment can effectively improve the prognosis of AD. Microglia were incubated with β-amyloid protein 1–42 (Aβ1–42) to construct an AD cell model. After microglia were activated, cell morphology changed, the expression level of inflammatory factors increased, cell apoptosis was promoted, and the expression of Tau protein and related proteins increased. By up-regulating and down-regulating Toll-like receptor 4 (TLR4), the cells were divided into Lv-NC group, Lv-TLR4 group, Sh-NC group, and Sh-TLR4 group. The expression of inflammatory factors was detected again. It was found that compared with the Lv-NC group, the expression of various inflammatory factors in the Lv-TLR4 group decreased, cell apoptosis was inhibited, and the expression of Tau protein and related proteins decreased. Compared with the Sh-NC group, the expression of inflammatory factors in the Sh-TLR4 group increased, cell apoptosis was promoted, and the expression of Tau protein and related proteins increased. These results indicate that Aβ1–42 may promote microglial activation and apoptosis by binding to TLR4. Reducing the expression of TLR4 can reduce the occurrence of inflammatory response in AD cells and slow down cell apoptosis. Therefore, TLR4 is expected to become a new target for the prevention and treatment of AD.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s DiseaseJournal of Alzheimer’s Disease, 2024
- Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s DiseaseJournal of Alzheimer’s Disease, 2024
- Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer diseasePhysiological Reviews, 2024
- Systematic characterization of a non-transgenic Aβ1–42 amyloidosis model: synaptic plasticity and memory deficits in female and male miceBiology of Sex Differences, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- The effects of microglia-associated neuroinflammation on Alzheimer’s diseaseFrontiers in Immunology, 2023
- Cattle Encephalon Glycoside and Ignotin Attenuates Aβ1-42-Mediated Neurotoxicity by Preventing NLRP3 Inflammasome Activation and Modulating Microglial Polarization via TLR4/NF-κB Signaling PathwayNeurotoxicity Research, 2022
- Innate Immune Cell Death in Neuroinflammation and Alzheimer’s DiseaseCells, 2022
- Oxymatrine inhibits neuroinflammation by Regulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathwayInternational Immunopharmacology, 2021
- TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's DiseaseFrontiers in Immunology, 2020